Wegovy 0.5mg is an FDA-approved weight loss injection that helps control appetite. Ideal for obesity management.
Description
Wegovy (0.5mg) is a weight loss medication approved by the FDA that helps you control your appetite and lose weight. It is a once-weekly, prefilled injection pen FlexTouch?. It belongs to the class of GLP?1 receptor agonists, mimicking the natural hormone GLP?1 which helps control appetite and enhance feelings of fullness.Benefits:Aids significant weight loss and long-term weight control in adults with obesity (BMI ??30?kg/m?) or overweight individuals (BMI ??27?kg/m?) with associated health conditions.Helps reduce the risk of serious heart-related events in adults with cardiovascular disease.Approved for weight management in adolescents aged 12 and older with obesity (weight over 60?kg), when lifestyle adjustments alone are insufficient.Main Ingredient & Its Benefits:Semaglutide: A synthetic GLP?1 agonist that promotes satiety, reduces appetite, slows gastric emptying, supports weight reduction, and metabolic improvements.How to use:Inject Wegovy once weekly, on the same day, at any time of the day, regardless of meal times.For best results, the recommended maintenance dose of Wegovy is 2.4 mg once weekly.Your treatment will start at a low dose of 0.25 mg once a week for 4 weeks, then gradually increase the dose every 4 weeks until you reach 2.4 mg.Start by confirming that the pen shows your prescribed dose and is clear and colorless.Attach a new NovoFine? Plus needle before each injection.Perform flow check (first use of each new pen): Hold the pen with the needle upward, align the flow-check marker, press the dose button until "0" appears drop should appear at the tip.Turn the selector to the prescribed dose, inject subcutaneously into the abdomen, thigh, or upper arm.Rotate injection sites with each weekly use.Store unopened pen refrigerated (2?8??C); do not freeze.Inject once weekly on the same day each week. If a dose is missed, it may be taken within 5 days; otherwise, skip it and return to the schedule.